J&J’s progress is being closely watched by top infectious disease experts because its vaccine has the potential to become the first that can protect people after just one shot. Photo: DPA J&J’s progress is being closely watched by top infectious disease experts because its vaccine has the potential to become the first that can protect people after just one shot. Photo: DPA
J&J’s progress is being closely watched by top infectious disease experts because its vaccine has the potential to become the first that can protect people after just one shot. Photo: DPA

Coronavirus pandemic

Coronavirus: Johnson & Johnson one-shot vaccine generates lasting response, interim results show

  • An early study found a long-lasting immune response in the single-dose vaccine, which could make mass-vaccination campaigns easier
  • Meanwhile, a UK study found Covid-19 infection gives some patients immunity for at least five months

Topic |   Coronavirus pandemic
J&J’s progress is being closely watched by top infectious disease experts because its vaccine has the potential to become the first that can protect people after just one shot. Photo: DPA J&J’s progress is being closely watched by top infectious disease experts because its vaccine has the potential to become the first that can protect people after just one shot. Photo: DPA
J&J’s progress is being closely watched by top infectious disease experts because its vaccine has the potential to become the first that can protect people after just one shot. Photo: DPA
READ FULL ARTICLE